Hyperfine Sets March 18, 2026, for Q4 and Full-Year 2025 Earnings Release

  • Hyperfine, Inc. (Nasdaq: HYPR) will report Q4 and full-year 2025 financial results on March 18, 2026.
  • The company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
  • Hyperfine's Swoop® system is the first FDA-cleared AI-powered portable MRI system for the brain.
  • The Swoop® system is designed for brain imaging of patients of all ages and is portable and ultra-low-field.

Hyperfine's upcoming earnings release comes at a critical juncture as the company seeks to solidify its position in the portable MRI market. The Swoop® system's FDA clearance and AI-powered capabilities position it as a disruptive force in brain imaging, potentially reshaping diagnostic practices. Investors will be watching closely to see if Hyperfine can translate its technological innovation into sustainable financial growth.

Revenue Growth
How Hyperfine's financial performance in 2025 will reflect the adoption and scalability of the Swoop® system in clinical settings.
Regulatory Compliance
Whether Hyperfine can maintain FDA clearance and expand the applications of its portable MRI technology.
Market Expansion
The pace at which Hyperfine can penetrate global markets with its innovative brain imaging solutions.
Hyperfine's Moment of Truth: Q4 Results to Test Portable MRI's Rise